Webinar: Developing new therapies using redox chemistry to target oxidative stress
A deep dive into PTC’s Bio-e platform – part of PTC’s multi-platform discovery and development engine
Hear an overview of the Bio-e platform, which provides information on oxidoreductase enzyme targets implicated in mitochondrial disease and seizures including:
Novel targets and compounds
A proprietary library
Our specialized approach and pipeline
This is a recording of our live webinar. This webinar recording has been chapterized to enable ease of viewing.
Register now to unlock the content
Register now to access the content on this page
Already registered?
If not, register below
US-MDAS-0203 | February 2022
Sign in or register to access exclusive content on this site
Register here to access the content on the site US-CORP-0330 | July 2022
You are now leaving MEDhub, a website provided by PTC Therapeutics. This link will take you to a website to which our Privacy Statement and our Terms and Conditions do not apply.
We encourage you to read the Privacy Policy and the Terms and Conditions of every website you visit. PTC Therapeutics does not endorse and/or influence the content found on websites not owned/operated by PTC Therapeutics.
The content you are trying to access is not currently available.
We will be updating the MEDhub site regularly to provide you with up-to-date, insightful expert-led content. To be notified when new additions become available, register now.